Carmen Pacilio

2.1k total citations
47 papers, 1.2k citations indexed

About

Carmen Pacilio is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Carmen Pacilio has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 17 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Carmen Pacilio's work include Estrogen and related hormone effects (12 papers), Cancer Treatment and Pharmacology (11 papers) and Breast Cancer Treatment Studies (10 papers). Carmen Pacilio is often cited by papers focused on Estrogen and related hormone effects (12 papers), Cancer Treatment and Pharmacology (11 papers) and Breast Cancer Treatment Studies (10 papers). Carmen Pacilio collaborates with scholars based in Italy, United States and Malaysia. Carmen Pacilio's co-authors include Antonio Giordano, Gaetano Romano, Pietro Micheli, Francesco Nuzzo, Adriano Gravina, Francesca Di Rella, Salvatore Florio, Pier Paolo Claudio, Luigi Cicatiello and Massimo Cancemi and has published in prestigious journals such as Journal of Clinical Oncology, Circulation Research and Cancer Research.

In The Last Decade

Carmen Pacilio

47 papers receiving 1.2k citations

Peers

Countries citing papers authored by Carmen Pacilio

Since Specialization

Citations

This map shows the geographic impact of Carmen Pacilio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Pacilio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Pacilio more than expected).

Fields of papers citing papers by Carmen Pacilio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Pacilio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Pacilio. The network helps show where Carmen Pacilio may publish in the future.

Co-authorship network of co-authors of Carmen Pacilio

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Pacilio. A scholar is included among the top collaborators of Carmen Pacilio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Pacilio. Carmen Pacilio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Overview of the Roles of CDK4/6 Inhibitors in Metastatic Breast Cancer Elderly Patients 2023 ·In Vivo ·Carmen Pacilio, Gerardo Rosati, Anna Crispo, Sabrina Bimonte, Francesca Di Rella, Francesco Nuzzo, Michelino De Laurentiis	5
2	The HOBOE-2 multicenter randomized phase III trial in premenopausal patients with hormone-receptor positive early breast cancer comparing triptorelin plus either tamoxifen or letrozole or letrozole + zoledronic acid 2018 ·Annals of Oncology ·Franco Perrone, Michelino De Laurentiis, Sabino De Placido, Michele Orditura, Saverio Cinieri, Ferdinando Riccardi, Angela Stefania Ribecco, Carlo Putzu, Lucia Del Mastro, Emanuela Rossi, Bruno Daniele, Anna Maria Mosconi, Francesca Di Rella, (unknown), Francesco Nuzzo, Carmen Pacilio, Rossella Lauria, Laura Arenare, Maria Carmela Piccirillo, Ciro Gallo	8
3	Weekly Docetaxel (Wd) Vs Cmf As Adjuvant Chemotherapy for Elderly Early Breast Cancer (Ebc) Patients (Pts): Final Results from the Randomised Phase 3 Elda Trial 2014 ·Annals of Oncology ·Francesco Perrone, Francesco Nuzzo, Francesca Di Rella, Adriano Gravina, (unknown), Carmen Pacilio, Michelino De Laurentiis, Sabino De Placido, Valeria Forestieri, Piera Gargiulo, Bruno Daniele, Vincenza Tinessa, Stefania Gori, Giuseppe Colantuoni, Sandro Barni, Ferdinando Riccardi, Maria Carmela Piccirillo, Marco Di Maio, Ciro Gallo, A. De Matteis	1
4	Ixabepilone Alone or With Cetuximab as First-Line Treatment for Advanced/Metastatic Triple-Negative Breast Cancer 2014 ·Clinical Breast Cancer ·Olivier Trédan, Mario Campone, Jacek Jassem, Rostislav Vyzula, Bruno Coudert, Carmen Pacilio, Jana Prausová, Anne-Claire Hardy-Bessard, Ana Arance, Pralay Mukhopadhyay, (unknown), Henri Roché	49
5	Imatinib treatment inhibit IL‐6, IL‐8, NF‐KB and AP‐1 production and modulate intracellular calcium in CML patients 2011 ·Journal of Cellular Physiology ·Roberto Ciarcia, (unknown), Massimiliano Galdiero, Carmen Pacilio, Valentina Iovane, Danila d’Angelo, (unknown), (unknown), Daniele Conti, (unknown), Salvatore Florio, Antonio Giordano	57
6	Relazione tra esposizione a bisfenolo A e B ed endometriosi 2010 ·CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche) ·Luigi Cobellis, (unknown), (unknown), (unknown), Carmen Pacilio, (unknown), Maria Antonietta Castaldi, (unknown), Antonio Borrelli	3
7	Dysregulated calcium homeostasis and oxidative stress in chronic myeloid leukemia (CML) cells 2010 ·Journal of Cellular Physiology ·Roberto Ciarcia, Danila d’Angelo, Carmen Pacilio, (unknown), Massimiliano Galdiero, Filomena Fiorito, Sara Damiano, Eliseo Mattioli, Chiara Lucchetti, Salvatore Florio, Antonio Giordano	30
8	Effetto della terapia con FSH ricombinante sulla frammentazione del DNA spermatico in pazienti affetti da oligoastenoteratozoospermia avviati a cicli ICSI 2009 ·CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche) ·Felice Fornaro, (unknown), (unknown), (unknown), Carmen Pacilio, Nicola Colacurci	1
9	Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: Safety data from the multicentre phase 3 randomised ELDA trial 2007 ·Critical Reviews in Oncology/Hematology ·Francesco Nuzzo, Alessandro Morabito, Ermelinda De Maio, Francesca Di Rella, Adriano Gravina, V. Labonia, Gabriella Landi, Carmen Pacilio, Maria Carmela Piccirillo, Emanuela Rossi, Giuseppe D’Aiuto, Renato Thomas, Stefania Gori, Mariantonietta Colozza, Sabino De Placido, Rossella Lauria, Giuseppe Signoriello, Ciro Gallo, Francesco Perrone, A. De Matteis	20
10	First-Line Chemotherapy for HER-2–Negative Metastatic Breast Cancer Patients Who Received Anthracyclines as Adjuvant Treatment 2007 ·The Oncologist ·Alessandro Morabito, Maria Carmela Piccirillo, (unknown), Carmen Pacilio, Francesco Nuzzo, Paolo Chiodini, Ciro Gallo, A. De Matteis, Francesco Perrone, (unknown)	5
11	Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial 2006 ·British Journal of Cancer ·(unknown), Carmen Pacilio, Alessandro Morabito, Francesco Nuzzo, Adriano Gravina, V. Labonia, (unknown), Emanuela Rossi, Ermelinda De Maio, Massimo Di Maïo, Giuseppe D’Aiuto, Gerardo Botti, Nicola Normanno, Paolo Chiodini, Ciro Gallo, Francesco Perrone, A. De Matteis	21
12	Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience 2005 ·BMC Cancer ·Ermelinda De Maio, Adriano Gravina, Carmen Pacilio, (unknown), V. Labonia, Gabriella Landi, Francesco Nuzzo, Emanuela Rossi, Giuseppe D’Aiuto, Immacolata Capasso, Massimo Rinaldo, Brunello Morrica, (unknown), Massimo Di Maïo, Federica Perrone, A. De Matteis	25
13	MPA increases idarubicin‐induced apoptosis in chronic lymphatic leukaemia cells via caspase‐3 2003 ·Journal of Cellular Biochemistry ·Salvatore Florio, (unknown), Roberto Ciarcia, Giovanni Vacca, Ugo Pagnini, A. De Matteis, Carmen Pacilio, Giuseppina D’Andrilli, (unknown), Antonio Giordano	4
14	Direct effect of a gonadotropin‐releasing hormone agonist on the growth of canine mammary tumour cells 2002 ·Journal of Cellular Biochemistry ·Ugo Pagnini, Salvatore Florio, (unknown), (unknown), Donato Colangelo, Daniela De Rocco, Carmen Pacilio, Maria Pacilio, Marcella Macaluso, Antonio Giordano	8
15	Inhibition of Human Breast Cancer Cell Growth by Blockade of the Mevalonate-Protein Prenylation Pathway is not Prevented by Overexpression of Cyclin D1 2001 ·Breast Cancer Research and Treatment ·(unknown), Carmen Pacilio, Massimo Cancemi, Luigi Cicatiello, Lucia Altucci, Valeria Belsito Petrizzi, (unknown), Salvatore Salzano, Rob Michalides, Yoichi Taya, Francesco Bresciani, Alessandro Weisz	3
16	Medroxyprogesterone acetate increases anthracyclines uptake in chronic lymphatic leukemia cells: role of nitric oxide and lipid peroxidation. 2000 ·PubMed ·Ugo Pagnini, Carmen Pacilio, Salvatore Florio, Antonio Crispino, Pier Paolo Claudio, Antonio Giordano, (unknown)	12
17	Prognostic Role of Cyclin D1 in Lung Cancer: Relationship to Proliferating Cell Nuclear Antigen 1999 ·American Journal of Respiratory Cell and Molecular Biology ·M Caputi, Angela M Groeger, Vincenzo Esposito, (unknown), Antonio De Luca, Carmen Pacilio, Michael Müller, Giovan Giacomo Giordano, Feliciano Baldi, Ernst Wolner, Antonio Giordano	55
18	Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study 1999 ·Annals of Oncology ·G. Frasci, N. Panza, P. Comella, Giacomo Cartenì, (unknown), G.P. Nicolella, Michèle Natale, Rosa Lombardi, Anna Apicella, Carmen Pacilio, Adriano Gravina, (unknown), G. Comella	35
19	Gene Transfer Technology in Therapy: Current Applications and Future Goals 1999 ·Stem Cells ·Gaetano Romano, Carmen Pacilio, Antonio Giordano	58
20	Gene Transfer Technology in Therapy: Current Applications and Future Goals 1998 ·The Oncologist ·Gaetano Romano, Carmen Pacilio, Antonio Giordano	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact